Short answer
AbbVie Inc (ABBV) filed an 8-K current report with the SEC on August 18, 2026 reporting Item 8.01 (Other Events). $10.0B senior notes issued on August 18, 2026, spanning maturities from 2028 to 2066.
AbbVie Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- $10.0B senior notes issued on August 18, 2026, spanning maturities from 2028 to 2066
- Fixed-rate coupons range from 4.500% to 6.100%; floating-rate notes mature in 2028
- Proceeds intended to fund part of Apogee acquisition cash consideration, fees, and general corporate purposes
- Acquisition termination triggers mandatory redemption of $8.5B notes at 101% plus accrued interest
- Unsecured debt increases AbbVie’s financing obligations while ranking equally with existing unsecured unsubordinated debt
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other AbbVie Inc 8-K filings
Get the next ABBV 8-K as it lands
Follow ABBV for push alerts, or ask the research agent what this filing means.